Skip to content
Home/Companies/Biotech/Trogenix
TR

Trogenix

Biotech·UK·Active·3yr hold

Trogenix is a biotech company, headquartered in UK.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Trogenix?

Trogenix is currently owned by 4Bio Partners through 4BIO Ventures III (2022 vintage), since 2023. Across its history, Trogenix has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-05-21

4Bio Partners
Most recent investor
4Bio Partners
4BIO Ventures III · 2022 · Life Sciences VC
3 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusActive

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by IQ Capital Partners, 4Bio Partners and Old College Capital since 2023.
Co-invest · 3 holders · 2023 · present
IQ Capital Partners
IQ Capital PartnersActive
2023 · present · IQ Capital Fund III · 2018 · VC
MOIC
–
4Bio Partners
4Bio PartnersActive
2023 · present · 4BIO Ventures III · 2022 · Life Sciences VC
MOIC
–
Old College Capital
Old College CapitalActive
2024 · present · Old College Capital LP · 2011 · Evergreen
MOIC
–

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Cytospire Therapeutics
Active
BiotechUK· 2026
Actithera
Active
BiotechSwitzerland· 2025
Hornet Therapeutics
Active
BiotechUK· 2024
March Biosciences
Active
BiotechUS· 2024
Ascend Advanced Therapies
Active
BiotechUK· 2023
ViaNautis Bio
Active
BiotechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings